Skip to main content
. 2024 Sep 1;5(1):e70005. doi: 10.1002/deo2.70005

TABLE 2.

Procedure and telephone follow‐up outcomes.

Total Non‐Anastomotic Anastomotic p‐value
N = 42 N = 15 N = 27
Procedure follow‐up
LAMS size 0.74
10 × 10 1 (2%) 0 (0%) 1 (4%)
15 × 10 12 (29%) 5 (33%) 7 (26%)
20 × 10 25 (60%) 8 (53%) 17 (63%)
15 × 15 4 (10%) 2 (13%) 2 (7%)
LAMS dilated 0.64
No 26 (62%) 10 (67%) 16 (59%)
Yes 16 (38%) 5 (33%) 11 (41%)
Technical success 42 (100%) 15 (100%) 27 (100%)
Post‐LAMS stenosis diameter (mm) 12.0 (10.0–15.0) 12.0 (11.0–15.0) 12.0 (10.0–15.0) 0.61
Change in stenosis diameter (mm) 8.0 (6.0–11.0) 9.0 (8.0–11.0) 7.0 (6.0–11.0) 0.34
>5 mm 29 (76%) 12 (80%) 17 (74%) 0.67
Stent dwell time (days) 91.0 (55.0–132.0) 64.5 (34.0–100.0) 100.0 (73.0–132.0) 0.1
>60 days 27 (69%) 8 (57%) 19 (76%) 0.22
>90 days 20 (51%) 4 (29%) 16 (64%) 0.034
Migration 10 (24%) 3 (20%) 7 (26%) 0.67
Adverse events 0.15
None 40 (95%) 13 (87%) 27 (100%)
Pneumonitis 1 (2%) 1 (7%) 0 (0%)
Retained stent 1 (2%) 1 (7%) 0 (0%)
Change in weight (lbs) 0.2 (‐2.0–9.5) 0.0 (‐4.8–7.0) 3.0 (0.0–10.6) 0.19
No change* 10 (28%) 4 (29%) 6 (27%) 0.2
Loss >1 lb 10 (28%) 6 (43%) 4 (18%)
Gained >1 lb 16 (44%) 4 (29%) 12 (55%)
Days to followed‐up 629.0 (192.0–1297.0) 868.0 (232.0–1304.0) 360.5 (173.0–852.0) 0.2
Vital Status
Alive 35 (95%) 11 (92%) 24 (96%)
Dead 2 (5%) 1 (8%) 1 (4%)
Early clinical success 28 (80%) 9 (69%) 19 (86%) 0.22
Late clinical success 28 (80%) 9 (69%) 19 (86%) 0.22
Post‐LAMS success 15 (45%) 6 (46%) 9 (45%) 0.95
Reintervention 24 (63%) 5 (33%) 19 (83%) 0.002
Type of reintervention
LAMS 10 (42%) 2 (40%) 8 (42%)
Dilation 11 (46%) 2 (40%) 9 (47%)
Dilation and stricturoplasty 3 (12%) 1 (20%) 2 (11%)
Days to reintervention 49.0 (20.0–105.0) 24.0 (20.0–38.0) 57.5 (26.0–105.0) 0.25